Structural studies on HIV reverse transcriptase related to drug discovery / David K. Stammers, Jingshan Ren
Zidovudine, lamivudine, and abacavir / Monica Carten, Harold Kessler
Stavudine, didanosine, and zalcitabine / Gail Skowron, Sapna Chowdhry, Michael R. Stevens
Emtricitabine / Gail Skowron, Jeffrey Bratberg, Rudi Pauwels
Nucleotide analogs / Craig Hoesley
Resistance to nucleoside and nucleotide reverse transcriptase inhibitors inhibitors / Nancy Shulman, Mark Winters
Pharmacokinetics of reverse transcriptase inhibitors / David Back
Peripheral neuropathy associated with nucleoside reverse transcriptase inhibitor therapy / Williams Cohen, Russel Bartt
Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: a pathophysiological perspective / William Lewis
Metabolic toxicity and lipodystrophy / Grace McComsey
Nevirapine / David Asmuth, Richard Pollard
Efavirenz / Graeme Moyle, Brian Conway
Delavirdine / Brian Conway
Resistance to non-nucleoside reverse transcriptase inhibitors / F. Ramsi Asfour, Richard Haubrich
Vertical transmission of HIV and therapeutic intervention / Susan Cu-Uvin, Arlene Bardeguez, Carla Chibwesha
New reverse transcriptase inhibitors in development / Rudi Pauwels
Antiretroviral drugs for millions / Allan Ronald, Ellie Katabira, Merle Sande.